Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/10562
Full metadata record
DC FieldValueLanguage
dc.contributor.authorBaker, Scott Ten
dc.contributor.authorChiang, Cherie Yingen
dc.contributor.authorZajac, Jeffrey Den
dc.contributor.authorBach, Leon Aen
dc.contributor.authorJerums, Georgeen
dc.contributor.authorMacIsaac, Richard Jen
dc.date.accessioned2015-05-16T00:03:44Z
dc.date.available2015-05-16T00:03:44Z
dc.date.issued2008-03-17en
dc.identifier.citationMedical Journal of Australia; 188(6): 340-3en
dc.identifier.govdoc18341457en
dc.identifier.otherPUBMEDen
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/10562en
dc.description.abstractTo investigate the relationship between admission glycaemic status and inpatient mortality in patients with and without pre-existing diabetes.Prospective observational cohort study.A general medical ward in an Australian tertiary referral hospital.903 patients admitted to the general medical ward between February 2003 and July 2004.Inpatient death.The overall inpatient mortality was 5.4% (n = 49). In the total cohort, age > 75 years and admission fasting plasma glucose (FPG) levels > or = 5.6 mmol/L were independent predictors of mortality. For patients without a known history of diabetes, each 1 mmol/L rise in admission FPG was associated with a 33% increase in mortality. In these patients, elevated (> 6.0%) and normal glycated haemoglobin (HbA(1c)) levels were associated with mortalities of 11.3% and 4.4%, respectively (odds ratio, 2.47; 95% CI, 1.16-5.26). In contrast, in patients with known diabetes, there was no association between admission FPG levels, HbA(1c) and mortality. Length of stay was not independently associated with FPG, HbA(1c), or diabetes status.In patients without known diabetes, the risk of death was increased for admission FPG levels > or = 5.6 mmol/L. However, pre-existing abnormal glucose metabolism, reflected by elevated HbA(1c) levels, appeared a more important predictor of inpatient mortality than glucose levels in patients without known diabetes.en
dc.language.isoenen
dc.subject.otherAgeden
dc.subject.otherAged, 80 and overen
dc.subject.otherAustralia.epidemiologyen
dc.subject.otherDiabetes Complicationsen
dc.subject.otherDiagnostic Tests, Routineen
dc.subject.otherFemaleen
dc.subject.otherHemoglobin A, Glycosylated.analysisen
dc.subject.otherHumansen
dc.subject.otherHyperglycemia.complications.mortalityen
dc.subject.otherInpatientsen
dc.subject.otherMaleen
dc.subject.otherProspective Studiesen
dc.titleOutcomes for general medical inpatients with diabetes mellitus and new hyperglycaemia.en
dc.typeJournal Articleen
dc.identifier.journaltitleMedical Journal of Australiaen
dc.identifier.affiliationAustin Health and University of Melbourne, Melbourne, VIC, Australiaen
dc.description.pages340-3en
dc.relation.urlhttps://pubmed.ncbi.nlm.nih.gov/18341457en
dc.type.austinJournal Articleen
local.name.researcherBaker, Scott T
item.cerifentitytypePublications-
item.languageiso639-1en-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.grantfulltextnone-
item.openairetypeJournal Article-
item.fulltextNo Fulltext-
crisitem.author.deptEndocrinology-
crisitem.author.deptEndocrinology-
crisitem.author.deptMedicine (University of Melbourne)-
crisitem.author.deptEndocrinology-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

24
checked on Feb 26, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.